​

COMPASS Pathways (CMPS) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

CMPS Stock Forecast

COMPASS Pathways (CMPS) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $18.57, with a high of $22.00 and a low of $15.00. This represents a 53.73% increase from the last price of $12.08.

- $5 $10 $15 $20 $25 High: $22 Avg: $18.57 Low: $15 Last Closed Price: $12.08

CMPS Stock Rating

COMPASS Pathways stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (92.31%), 1 Hold (7.69%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 1 12 0 Strong Sell Sell Hold Buy Strong Buy

CMPS Price Target Upside V Benchmarks

TypeNameUpside
StockCOMPASS Pathways53.73%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks25.91%
IdeaPsychedelic Stocks List88.77%

Price Target Trends

1M3M12M
# Anlaysts-511
Avg Price Target-$18.00$18.27
Last Closing Price$12.08$12.08$12.08
Upside/Downside-49.01%51.24%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 263111--15
May, 26391--13
Apr, 26381--12
Mar, 26371--11
Feb, 26371--11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2026Jason McCarthyMaxim Group$20.00$10.4092.31%65.56%
May 14, 2026Judah FrommerMorgan Stanley$17.00$10.9455.39%40.73%
May 07, 2026UBS$18.00$9.2694.38%49.01%
May 03, 2026Jefferies$18.00$9.0199.78%49.01%
Apr 24, 2026UBS$17.00$8.8791.66%40.73%
Feb 18, 2026RBC Capital$22.00$8.78150.57%82.12%
Feb 18, 2026Vikram PurohitMorgan Stanley$18.00$7.63135.91%49.01%
Feb 18, 2026Sumant KulkarniCanaccord Genuity$20.00$7.63162.12%65.56%
Feb 12, 2026Francois BriseboisCompass Point$15.00$6.31137.72%24.17%
Jan 23, 2026Leonid TimashevRBC Capital$21.00$7.17192.89%73.84%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 01, 2026Cowen & Co.BuyBuyhold
May 22, 2026Raymond JamesBuyBuyhold
May 22, 2026Wolfe ResearchOutperforminitialise
May 14, 2026Morgan StanleyOverweightOverweighthold
May 03, 2026JefferiesBuyinitialise
Apr 24, 2026B. RileyBuyinitialise
Feb 18, 2026RBC CapitalOutperformOutperformhold
Feb 18, 2026Morgan StanleyOverweightOverweighthold
Jan 23, 2026RBC CapitalOutperformOutperformhold
Dec 09, 2025OppenheimerOutperformOutperformupgrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.32$-2.30$-3.08---
Avg Forecast$-2.15$-2.37$-2.07$-1.76$-1.44$-0.96
High Forecast$-1.92$-2.24$-1.69$-1.76$-1.44$-0.96
Low Forecast$-2.38$-2.69$-2.66$-1.76$-1.44$-0.96
Surprise %7.91%-2.95%48.79%---

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast---$560.00K$10.47M$169.80M
High Forecast---$560.00K$10.47M$169.80M
Low Forecast---$560.00K$10.47M$169.80M
Surprise %------

Net Income Forecast

$-300M $-240M $-180M $-120M $-60M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-118.46M$-155.12M$-287.86M---
Avg Forecast$-109.85M$-120.75M$-105.74M$-89.55M$-73.48M$-48.78M
High Forecast$-98.13M$-114.53M$-86.01M$-89.55M$-73.48M$-48.78M
Low Forecast$-121.57M$-137.33M$-135.59M$-89.55M$-73.48M$-48.78M
Surprise %7.84%28.46%172.23%---

CMPS Forecast FAQ

Is COMPASS Pathways stock a buy?

COMPASS Pathways stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that COMPASS Pathways is a favorable investment for most analysts.

What is COMPASS Pathways's price target?

COMPASS Pathways's price target, set by 13 Wall Street analysts, averages $18.57 over the next 12 months. The price target range spans from $15 at the low end to $22 at the high end, suggesting a potential 53.73% change from the previous closing price of $12.08.

How does COMPASS Pathways stock forecast compare to its benchmarks?

COMPASS Pathways's stock forecast shows a 53.73% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (25.91%), trailing the Psychedelic Stocks List (88.77%) investment idea.

What is the breakdown of analyst ratings for COMPASS Pathways over the past three months?

  • June 2026: 20.00% Strong Buy, 73.33% Buy, 6.67% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 23.08% Strong Buy, 69.23% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 25.00% Strong Buy, 66.67% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.

What is COMPASS Pathways’s EPS forecast?

COMPASS Pathways's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.76, marking a -42.86% decrease from the reported $-3.08 in 2025. Estimates for the following years are $-1.44 in 2027, and $-0.96 in 2028.

What is COMPASS Pathways’s revenue forecast?

COMPASS Pathways's average annual revenue forecast for its fiscal year ending in December 2026 is $560K, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $10.47M, and $169.8M for 2028.

What is COMPASS Pathways’s net income forecast?

COMPASS Pathways's net income forecast for the fiscal year ending in December 2026 stands at $-89.554M, representing a -68.89% decrease from the reported $-288M in 2025. Projections indicate $-73.48M in 2027, and $-48.783M in 2028.